Novel Diabetes Medications and Diabetic Retinopathy

In this webinar, we will will focus on GLP1 and ophthalmic risk.

Overview

Join other American Diabetes Association® (ADA) professional members on January 22, 2025 from 11:30 a.m. to 12:30 p.m. EST for a live, one-hour webinar, Novel Diabetes Medications and Diabetic Retinopathy. In this webinar, we will will focus on GLP1 and ophthalmic risk.

Learning Objectives

Discuss novel diabetes medications (GLP1, SGLT2, etc) and diabetic retinopathy
Recognizing nonarteritic anterior ischemic optic neuropathy in people with diabetes

Speaker

Andrew J. Barkmeier, M.D.
Mayo Clinic

Moderators

	Blake Cooper, MD, MPH Retina Associates
	Risa Wolf, MD John Hopkins University School of Medicine

Summary


Availability:	No future session


Cost:	FREE


Credit Offered:	No Credit Offered

Create Account